Zonisamide decreases cortical excitability in patients with idiopathic generalized epilepsy.

Author(s): Joo EY, Kim SH, Seo DW, Hong SB

Affiliation(s): Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea.

Publication date & source: 2008-06, Clin Neurophysiol., 119(6):1385-92. Epub 2008 Apr 8.

Publication type: Controlled Clinical Trial; Research Support, Non-U.S. Gov't

OBJECTIVE: To evaluate changes in cortical excitability after long-term zonisamide (ZNS) administration. METHODS: Fifteen drug-naive idiopathic generalized epilepsy (IGE) patients (8 male, mean age 24.9 years) were enrolled. The transcranial magnetic stimulation (TMS) parameters obtained using two Magstim 200 stimulators were resting motor threshold (RMT), motor evoked potential (MEP) amplitudes, cortical silent period (CSP), intracortical inhibition (ICI), and intracortical facilitation (ICF). TMS parameters were compared before and after ZNS administration. RESULTS: All patients were administered ZNS monotherapy (200 mg/day) for 8 weeks. No patient reported seizures during the study period. After ZNS treatment MEP amplitudes were significantly reduced in right (-34.2%) and left hemispheres (-37.0%) (Wilcoxon's signed rank test after Bonferroni's correction for multiple comparisons, P < 0.05). Mean RMT, CSP, and ICI/ICF were not changed by ZNS (P > 0.05). CONCLUSIONS: These findings suggest that ZNS decreases cortical excitability in patients with IGE and a MEP amplitude is a useful TMS parameter for evaluating changes in cortical excitability induced by ZNS. SIGNIFICANCE: The findings in this study are helpful to understand how ZNS affects the excitability of the motor cortex in patients with IGE.